|
|
|
|
|
by tansey
1566 days ago
|
|
PI at a cancer center here. These two ideas are not mutually exclusive. Cancer is indeed not 1 disease but many countless ones. At the same time, cancer diagnoses are based on site of origin and histology (how it looks under a microscope). But often what drives a cell of one tissue toward pathogenesis is the same mutation or other molecular malfunction as a cell of another tissue type. In those cases, we can develop drugs that target that specific component and it may work across both cancer types. Unfortunately, there are countless ways things can go wrong in cells. There are also rarely drugs that truly span a large swath of cancer types effectively. That's because even though two cancers from different sites may have the same driver, how they respond to treatments can differ. The difference in cell state may allow one of the two cancers to adapt to the treatment, such as by activating an alternative growth pathway, whereas the other cancer type's cell of origin may not have such an easy road to therapeutic escape. |
|